Past Events

Results 1 to 12 of 1455
CND 67th Session Reconvened

CND 67th Session Reconvened

Online / Vienna, Austria
5 December 2024 - 6 December 2024
The continuation of the 67th session takes place in December 2024.
6th European Harm Reduction Conference

6th European Harm Reduction Conference

Warsaw, Poland
2 December 2024 - 4 December 2024
The conference will present the latest harm reduction developments and innovative practices and discuss drug policy and its implications on people who use drugs and other marginalised groups.
AWID International Forum 2024

AWID International Forum 2024

Bangkok, Thailand
2 December 2024 - 5 December 2024
The 15th AWID International Forum will take place from December 2-5, 2024 in Bangkok, Thailand where Global South feminists and historically marginalised communities will mobilise to connect with allied movements, funders and policy-makers.
Evidence-based drug policies and harm reduction strategies

Evidence-based drug policies and harm reduction strategies

Vienna, Austria / Online
12 November 2024
This event will explore evidence-based approaches to drug policy and harm reduction strategies, bringing together experts to discuss public health-focused responses within international policy frameworks.
 HIT Hot Topics 2024

HIT Hot Topics 2024

Liverpool, UK
8 November 2024
Registration now open for HIT Hot Topics 2024 in Liverpool, United Kingdom.
BOOST’s peer-to-peer capacity-building webinar series

BOOST’s peer-to-peer capacity-building webinar series

Online
6 November 2024 - 27 November 2024
The webinars aim to enhance the knowledge and skills of community-based and community-led organisations, helping them apply good practice models, tools, and methods to scale up integrated screening, testing, treatment and care for communicable diseases across Europe. 
6th Asia Pacific Chemsex Symposium - APCS 2024

6th Asia Pacific Chemsex Symposium - APCS 2024

Bangkok, Thailand
6 November 2024 - 7 November 2024
APCS 2024 is hosted in Bangkok, this year the symposium will spotlight key populations, HIV/STI prevention, mental health, and harm reduction.